Login
Register
Back to News
Intensity Therapeutics Regains Nasdaq Minimum Bid Price Compliance After 10 Consecutive Business Days Of Closing Bid At Or Above $1
Benzinga Newsdesk
www.benzinga.com
Positive 94.3%
Neg 0%
Neu 0%
Pos 94.3%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment